A study to compare the effectiveness of a local anaesthetic drug (isobaric Levobupivacaine) when used alone and when combined with an an opioid drug (Fentanyl} in supraclavicular block under ultrasound guidance for patients undergoing elective elbow and forearm orthopaedic surgeries

A comparative study of isobaric Levobupivacaine and isobaric Levobupivacaine with Fentanyl in ultrasound guided supraclavicular block for patients undergoing elective elbow and forearm orthopaedic surgeries - N/A

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067709

Enrollment

Registered

2024-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: InjLevobupivacaine: 20ml of InjLevobupivacaine(isobaric) 0.5% with 10ml of normal saline as single dose in supraclavicular plexus block Control Intervention1: InjLevobupivacaine with In

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for elective elbow and forearm orthopaedic surgeries with American society of anaesthesiologists ASA physical status class 1 and 2 Patients who have given informed consent Patients with no known hypersensitivity to local anaesthetic agents of amide type of drugs

Exclusion criteria

Exclusion criteria: Known to have allergy to any study drugs Age below 18 or above 60 Any local infection Any history of pulmonary/cardiac/renal or endocrine disease Patients with history of coagulation disorders or history of anticoagulant intake

Design outcomes

Primary

Measure	Time frame
To study the onset and duration of postoperative analgesia after brachial plexus blockTimepoint: immediately after block and in postoperative period	—

Secondary

Measure	Time frame
Hemodynamic characteristics of the two drug groups Requirement of first rescue analgesiaTimepoint: 2hours	—

Countries

India

Contacts

Public ContactDr Renju Raj

Chamarajanagar institute of medical sciences

darshanms_jss@yahoo.com9741376797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026